Daxor Corporation
NASDAQ:DXR · NASDAQ Capital Market
+$0.33 today
Vol 0.00M · Avg 0.01M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:DXR · Revenue to Net Income
Key Ratios
Analysis
$917.3K of revenue converted into $9.7M of net income for the selected period. Gross margin is 52.5% and net margin is 814.8%, showing how much revenue survives after costs and taxes. EPS is $1.92, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $503.4K -76.4% | $2.1M -93.8% | $34.6M +9889.0% | -$353.4K +86.5% | -$2.6M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $314.7K | $0 -100.0% | $177.1K -83.7% | $1.1M +8.5% | $1.0M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $188.7K -91.1% | $2.1M -93.8% | $34.4M +2489.1% | -$1.4M +60.2% | -$3.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 37.5% -62.5pp | 100.0% +0.5pp | 99.5% -308.2pp | 407.6% +269.3pp | 138.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 +100.0% | -$15 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $0 -100.0% | $294.2K -4.3% | $307.4K -71.7% | $1.1M +9.5% | $991.3K | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | -$9.0M -664.2% | $1.6M +69.8% | $939.1K -13.5% | $1.1M +1.2% | $1.1M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $0 -100.0% | $1.4M +183.5% | $506.8K -41.0% | $859.7K +15.3% | $745.6K | $374.2M | $1.2B | $631.8M |
| EBITDA | $9.2M +346.3% | $2.1M +524.2% | $329.7K -94.6% | $6.1M +28.7% | $4.7M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 1824.7% +1728.1pp | 96.6% +95.6pp | 1.0% +1730.2pp | -1729.2% -1547.7pp | -181.6% | 5.6% | 46.3% | 42.0% |
| Operating Income | $9.2M +1378.2% | $621.4K +88.5% | $329.7K -93.7% | $5.3M +10.6% | $4.7M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 1824.7% +1795.5pp | 29.2% +28.2pp | 1.0% +1486.9pp | -1485.9% -1304.4pp | -181.6% | 16.6% | 24.1% | 22.0% |
| Interest Income | $26.7K | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $16.0K -81.2% | $85.1K +73.3% | $49.1K -32.2% | $72.5K +269.6% | $19.6K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$16.0K +81.2% | -$85.1K -73.3% | -$49.1K +32.2% | -$72.5K -269.6% | -$19.6K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $9.2M +1609.7% | $536.3K +91.1% | $280.6K -94.6% | $5.2M +9.1% | $4.7M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 1821.5% +1796.3pp | 25.2% +24.4pp | 0.8% +1466.2pp | -1465.4% -1283.8pp | -181.6% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | $9.2M +1609.7% | $536.3K +91.1% | $280.6K -94.6% | $5.2M +9.1% | $4.7M | $4.9B | $4.8B | $4.7B |
| Net Margin | 1821.5% +1796.3pp | 25.2% +24.4pp | 0.8% +1466.2pp | -1465.4% -1283.8pp | -181.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $2 +1572.7% | $0 +81.5% | $0 -89.9% | $1 -49.2% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $2 +1572.7% | $0 +81.5% | $0 -89.9% | $1 -49.2% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $5.0M +2.9% | $4.8M +4.6% | $4.6M -46.0% | $8.6M +112.6% | $4.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $5.0M +2.9% | $4.8M +4.6% | $4.6M -46.0% | $8.6M +112.6% | $4.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Adagene Inc.
NASDAQ:ADAG
$132.15M
Gain Therapeutics, Inc.
NASDAQ:GANX
$76.35M
Great Elm Group, Inc.
NASDAQ:GEG
$73.69M
Adicet Bio, Inc.
NASDAQ:ACET
$72.54M
XBiotech Inc.
NASDAQ:XBIT
$71.65M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$68.62M
CervoMed Inc.
CRVO
$41.85M
Nephros, Inc.
NEPH
$34.63M
Lite Strategy, Inc.
LITS
$31.30M
HeartBeam, Inc.
BEAT
$24.94M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DXR generate?
Daxor Corporation (DXR) reported $503,424.00 of revenue in fiscal 2025.
Is DXR profitable?
Daxor Corporation (DXR) reported $9.17M of net income, with a net margin of 1821.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.